Aneurysmal subarachnoid hemorrhage (SAH) is a poor-outcome disease with a delayed
neurological exacerbation. Fibulin-5 (FBLN5) is one of matricellular proteins, some of which …

Background and purpose The aim was to investigate relationships between serum fibulin‐5
concentration and the severity or prognosis in patients with acute intracerebral haemorrhage …

Background Fibulin-5 and ischemia-modified albumin (IMA) levels increase in acute phase
of cerebrovascular diseases, yet data regarding their levels in various stroke subtypes and …

Objectives Multiple cytokines have been implicated in aneurysmal subarachnoid
hemorrhage (aSAH), but tumor necrosis factor superfamily 14 (LIGHT/TNFSF14) and …

Objectives Serum neurofilament light chain (NfL) is a biomarker for neuroaxonal damage,
and S100B is a blood marker for cerebral damage. In the present study, we investigated the …

Background Aneurysmal subarachnoid hemorrhage (aSAH) is associated with activation of
the inflammatory cascade contributing to unfavorable outcome and secondary …

Growth differentiation factor 15 (GDF-15), neutrophil gelatinase-associated lipocalin (NGAL),
and ADAMTS13 have previously been implicated in the pathophysiological processes of …

Abstract Ischemia/reperfusion (I/R) injury after middle cerebral artery occlusion (MCAO)
induces detrimental processes such as oxidative stress, inflammation, and apoptosis. All …

Background The molecular mechanisms underlying cerebral vasospasm and delayed
cerebral ischemia (DCI) after aneurysmal subarachnoid hemorrhage (aSAH) are …

Objective To determine whether leucine-rich alpha-2 glycoprotein 1 (LRG1) is a potential
prognostic and severity biomarker in patients with aneurysmal subarachnoid hemorrhage …